News

The Independent Neurorehabilitation Providers Alliance (INPA), which represents specialist health and social care firms in the UK, has a new leader.

The search for a motor neurone disease cure has uncovered a way of potentially slowing the disease by boosting energy production in the central nervous system.

Over 5,000 brain injury survivors in the UK are now carrying an ID card designed to help police and other professionals to understand their circumstances.

An upcoming webinar aims to give social workers more clarity on newly refreshed guidance on working with people affected by brain injury.

Future Cannabis Strategies Europe brings together influencers from major European cannabis companies, including CBD oil producers, to discuss the future of the legal cannabis industry. Topics up for discussion include how manufacturers can understand trends and demands from European cannabis derived product consumers. They will also review recent product innovation to understand how market trends [...]

Neuroball, invented by UK firm Neurofenix, was chosen from a shortlist of the UK’s 10 best “garden shed inventions” that could seriously transform people’s lives. The competition was sponsored by innovation foundation Nesta and supported by the government. Neuroball allows stroke patients to engage in rehabilitation exercises at home and was inspired by relatives of [...]

The shuffling and whispers of the conference crowd ceased entirely when Yorkshireman Stephen shared his story. The brain injury survivor recalled the last thing his wife ever said to him before the overdose that killed her. “I just want my old Steph back”, he quoted to a watching audience of delegates. Even battle-hardened brain injury [...]

Community Case Management Services (CCMS) has transformed a 17th Century large dilapidated farmhouse and an adjoining stone barn in an idyllic corner of Normandy into an accessible holiday venue and retreat. The retreat offers people with subtle to high- level disabilities a place in which to relax with friends and loved ones in the heart [...]

It is believed the drug – usually used to treat diabetes – can help to restore brain activity before symptoms of the terminal illness become established. Research published in the journal eLife found that the drug can help to regulate the Huntingtin protein, which in a mutated form can accumulate in the brain, leading to [...]

It is hoped that the study – the third and final phase of the trial into the drug simvastatin - will lay the foundations for an effective SPMS treatment, which is currently lacking. The MS-STAT2 trial will involve 1,180 people with SPMS and confirm whether simvastatin could slow or stop disability progression in SPMS cases, [...]